Two dedicated volunteers have reached a prestigious milestone with the American Heart Association, the world’s leading nonprofit organization devoted to a world of healthier lives for all, for their personal passion and commitment to advance women’s heart health.
CHMP recommends rejecting Amylyx ALS drug, pitting EMA against FDA and Health Canada
The European Medicines Agency recommended that Amylyx Pharmaceuticals’ ALS drug be rejected within the EU. The drug, known as Relyvrio in the US and Albrioza